Washington Statutes
§ 70.54.130 — Laetrile—Legislative declaration.
Washington § 70.54.130
JurisdictionWashington
Title 70PUBLIC HEALTH AND SAFETY
Ch. 70.54MISCELLANEOUS HEALTH AND SAFETY PROVISIONS
This text of Washington § 70.54.130 (Laetrile—Legislative declaration.) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Wash. Rev. Code § 70.54.130 (2026).
Text
It is the intent of the legislature that passage of RCW 70.54.130 through 70.54.150 shall not constitute any endorsement whatever of the efficacy of amygdalin (Laetrile) in the treatment of cancer, but represents only the legislature's endorsement of a patient's freedom of choice, so long as the patient has been given sufficient information in writing to make an informed decision regarding his/her treatment and the substance is not proven to be directly detrimental to health.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
[1977 ex.s. c 122 s 1.]
Nearby Sections
15
§ 70.01.030
Health care fees and charges—Estimate.§ 70.01.040
Provider-based clinics that charge a facility fee—Posting of required notice—Reporting requirements.§ 70.02.005
Findings.§ 70.02.010
Definitions.(Effective until June 30, 2027.)§ 70.02.020
Disclosure by health care provider.§ 70.02.045
Third-party payor release of information.§ 70.02.060
Discovery request or compulsory process.Cite This Page — Counsel Stack
Bluebook (online)
Washington § 70.54.130, Counsel Stack Legal Research, https://law.counselstack.com/statute/wa/70.54.130.